RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 New Treatments: Sitagliptin
JF MD Conference Express
YR 2006
FD SAGE Publications
VO 6
IS 2
SP 17
OP 17
DO 10.1177/155989770600600209
UL http://mdc.sagepub.com/content/6/2/17.1.abstract
AB Sitagliptin is a once-daily oral medication in the depeptidyl-peptidase-4 (DPP-4) inhibitor class of medications. This article discusses data from a phase 3 non-inferiority trial of sitagliptin versus glipizide.